HAIR GROWTH PDRN Injɛkshɔn we dɛn kin yuz
Fɔ chenj frɔm Saxenda (liraglutide, ɛvride) to Wegovy (semaglutide, ɛvri wik) na kɔmɔn tin fɔ di sik pipul dɛn we de tray fɔ lɔs mɔ wet ɔ fɔ gɛt smɔl injɛkshɔn. Bays pan di ɔfishal US lɛbl ɛn di gayd we dɛn dɔn pablish, dis gayd de ɛksplen wetin mek di sikman dɛn de chenj, kɔmpia di dos schedule, ɛn sho di transishɔn stɛp bay stɛp: nɔ was-ɔt nid fɔ was, Wegovy kin ɔltɛm stat di de afta di las Saxenda doz, di stat doz na tipikli 0.25 mg (0.5 mg dɛn kin tek am se na ɔf-lɛbul fɔ sɔm pasɛnt dɛn we stebul pan 3 mg), ɛn eskalayshɔn kin apin ɛvri 4 wik dɛn. I de kɔba bak di GI sayd ifɛkt dɛn we dɛn de ɛkspɛkt, STEP 8 trayal rizɔlt, kɔmɔn mistek dɛn ɛn wetin di GLP-1 tren min fɔ aesthetic klinik ɛn distribyushɔn.
View MoreTranexamic acid (TXA) mesotherapy dɔn bi wan go-to opshɔn fɔ klinik dɛn we de trit stɛp-bɔn mɛlasma. Dis gayd de ɛksplen aw TXA de intarap di plasmin signal we de drɛb pigmɛnt prodakshɔn, wetin dɛn dɔn pablish klinik stɔdi dɛn sho (Lee 2006; Budamakuntla 2013), aw dɛn de rɔn wan tipik intradamal TXA protɔkɔl, we brayt aktiv dɛn we i de pe fayn wit, ki sefty kɔnsidareshɔn dɛn, ɛn wan sɔs chɛklist fɔ distribyushɔn ɛn klinik brand dɛn we de luk =
View More